Page All:
Page 1
CardioSecur: 22-Lead Mobile ECG Enables 360-Degree View of the Heart
LONDON, September 1, 2015 /PRNewswire/ --
Personal MedSystems introduces the first and only 22-lead mobile ECG system,
CardioSecur, at the European Society of Cardiology Congress 2015. The next generation of
ECG solutions can be run with a smartphone or tablet PC, 4 electrodes and the CardioSecur
App enabling the diagnosis and localization of cardiac ischemia, rhythm disorders and
posterior wall infarctions. Clinical grade quality readings allow a 360-degree view of the
heart and therefore new diagnostic possibilities. CardioSecur's technology has been
validated in several clinical studies[1] and is available in two versions: CardioSecur PRO
for professional use and CardioSecur ACTIVE for home use by patients. Â
The conventional 12-lead ECG has surely proven its worth in the diagnosis of cardiac
disease. Nevertheless the display possibilities of a 12-lead ECG are limited to only 65
degrees in the transverse plane. This might be one of the reasons up to half of people who
suffer from angina or silent ischemia, have normal ECG readings[2]. In Europe alone,
Coronary Artery Disease still accounts for 4 million deaths every year.[3] Symptoms for
myocardial infarction are often indistinct while about one out of three heart attacks
occurs symptom free[4] which makes precise diagnosis even more difficult. Next to modern
therapy options the need for enhanced diagnosis tools supporting physicians is crucial.
Quality and accuracy of the mobile ECG solution CardioSecur has been validated in a
clinical study against standard of care 10 electrode, 12-lead ECG systems and shows 99.5%
accuracy.[5] Using only 4 electrodes mitigates artifacts to a bare minimum ensuring
maximum signal quality and exceptionally stable lead depiction. As the 4 electrodes are
placed on very marked positions of the thorax, lead misplacement, often consequential to
highly divers anatomies, is eradicated.
Professional and Patient Version based on identical smart technologyÂ
CardioSecur has been developed by cardiologists in two versions: The professional
22-lead version CardioSecur PRO enables use in house calls, bed-ridden or reduced mobility
patients as well as emergency situations. The lightweight 50g cable is accompanied by the
PRO app which allows 10.000 minutes of ECG recording per 1GB via smartphone or tablet PC.
The full ECG report can be sent directly to electronic patient records or colleagues and
can be air printed. An automatic interpretation function is also available.
--------------------------------------------------
1. Drew, B.J. and B. Ide, Diagnosing ischemia from the bedside monitor. Prognostic
Cardiovascular Nursing, 1996. 11(1): p. 45-6.; Bonaventura K, Wellnhofer E, Fleck E.
Comparison of standard and derived 12-lead electrocardiograms registrated by a simplified
3-lead setting with four electrodes for diagnosis of coronary angioplasty-induced
myocardial ischemia. European Cardiology. 2012 Jul;8(3):179.
2. http://umm.edu/health/medical/reports/articles/coronary-artery-disease
3. European Heart Network and European Society of Cardiology: European Cardiovascular
Disease Statistics, Sept. 2012, 14
4. Sheifer SE, Manollo TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern
Med 2001;135:801-811
5. Bonaventura K, Wellnhofer E, Fleck E. Comparison of standard and derived 12-lead
electrocardiograms registrated by a simplified 3-lead setting with four electrodes for
diagnosis of coronary angioplasty-induced myocardial ischemia. European Cardiology. 2012
Jul;8(3):179.
CardioSecur ACTIVE is the convenient 15-lead patients' version of the mobile ECG
enabling doctors to get data from the very moment patients suffer from cardiac symptoms.
CardioSecur ACTIVE can be used in patients with undiagnosed symptoms, high risk patients
as well as those who have had a cardiac event. While patients get simple instructions to
act and - if necessary - contact their physician, the ECG is sent via email to the medical
specialist for further use. Shared via a secure database helpful information for diagnosis
and patient management is generated.
About Personal MedSystems:Â
CardioSecur is is an innovation of Personal MedSystems GmbH, based in Frankfurt am
Main, Germany. The high tech start-up company is financed by venture capital firms
Seventure Partners and High Tech Gründerfonds. Personal MedSystems received the ISO 13485
certification from TüV SüD in 2011.
http://www.mobile-ecg.com
Â
Press contact:Â
Personal MedSystems GmbHÂ
Maria KevorkovaÂ
Hansaallee 154Â
60320 Frankfurt am Main/ GermanyÂ
kevorkova@cardiosecur.com Â
+49(0)69-210065-00Â
Â
Personal MedSystems GmbH
CardioSecur: 22-Lead Mobile ECG Enables 360-Degree View of the Heart
LONDON, September 1, 2015 /PRNewswire/ --
Personal MedSystems introduces the first and only 22-lead mobile ECG system,
CardioSecur, at the European Society of Cardiology Congress 2015. The next generation of
ECG solutions can be run with a smartphone or tablet PC, 4 electrodes and the CardioSecur
App enabling the diagnosis and localization of cardiac ischemia, rhythm disorders and
posterior wall infarctions. Clinical grade quality readings allow a 360-degree view of the
heart and therefore new diagnostic possibilities. CardioSecur's technology has been
validated in several clinical studies[1] and is available in two versions: CardioSecur PRO
for professional use and CardioSecur ACTIVE for home use by patients. Â
The conventional 12-lead ECG has surely proven its worth in the diagnosis of cardiac
disease. Nevertheless the display possibilities of a 12-lead ECG are limited to only 65
degrees in the transverse plane. This might be one of the reasons up to half of people who
suffer from angina or silent ischemia, have normal ECG readings[2]. In Europe alone,
Coronary Artery Disease still accounts for 4 million deaths every year.[3] Symptoms for
myocardial infarction are often indistinct while about one out of three heart attacks
occurs symptom free[4] which makes precise diagnosis even more difficult. Next to modern
therapy options the need for enhanced diagnosis tools supporting physicians is crucial.
Quality and accuracy of the mobile ECG solution CardioSecur has been validated in a
clinical study against standard of care 10 electrode, 12-lead ECG systems and shows 99.5%
accuracy.[5] Using only 4 electrodes mitigates artifacts to a bare minimum ensuring
maximum signal quality and exceptionally stable lead depiction. As the 4 electrodes are
placed on very marked positions of the thorax, lead misplacement, often consequential to
highly divers anatomies, is eradicated.
Professional and Patient Version based on identical smart technologyÂ
CardioSecur has been developed by cardiologists in two versions: The professional
22-lead version CardioSecur PRO enables use in house calls, bed-ridden or reduced mobility
patients as well as emergency situations. The lightweight 50g cable is accompanied by the
PRO app which allows 10.000 minutes of ECG recording per 1GB via smartphone or tablet PC.
The full ECG report can be sent directly to electronic patient records or colleagues and
can be air printed. An automatic interpretation function is also available.
--------------------------------------------------
1. Drew, B.J. and B. Ide, Diagnosing ischemia from the bedside monitor. Prognostic
Cardiovascular Nursing, 1996. 11(1): p. 45-6.; Bonaventura K, Wellnhofer E, Fleck E.
Comparison of standard and derived 12-lead electrocardiograms registrated by a simplified
3-lead setting with four electrodes for diagnosis of coronary angioplasty-induced
myocardial ischemia. European Cardiology. 2012 Jul;8(3):179.
2. http://umm.edu/health/medical/reports/articles/coronary-artery-disease
3. European Heart Network and European Society of Cardiology: European Cardiovascular
Disease Statistics, Sept. 2012, 14
4. Sheifer SE, Manollo TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern
Med 2001;135:801-811
5. Bonaventura K, Wellnhofer E, Fleck E. Comparison of standard and derived 12-lead
electrocardiograms registrated by a simplified 3-lead setting with four electrodes for
diagnosis of coronary angioplasty-induced myocardial ischemia. European Cardiology. 2012
Jul;8(3):179.
CardioSecur ACTIVE is the convenient 15-lead patients' version of the mobile ECG
enabling doctors to get data from the very moment patients suffer from cardiac symptoms.
CardioSecur ACTIVE can be used in patients with undiagnosed symptoms, high risk patients
as well as those who have had a cardiac event. While patients get simple instructions to
act and - if necessary - contact their physician, the ECG is sent via email to the medical
specialist for further use. Shared via a secure database helpful information for diagnosis
and patient management is generated.
About Personal MedSystems:Â
CardioSecur is is an innovation of Personal MedSystems GmbH, based in Frankfurt am
Main, Germany. The high tech start-up company is financed by venture capital firms
Seventure Partners and High Tech Gründerfonds. Personal MedSystems received the ISO 13485
certification from TüV SüD in 2011.
http://www.mobile-ecg.com
Â
Press contact:Â
Personal MedSystems GmbHÂ
Maria KevorkovaÂ
Hansaallee 154Â
60320 Frankfurt am Main/ GermanyÂ
kevorkova@cardiosecur.com Â
+49(0)69-210065-00Â
Â
Personal MedSystems GmbH